elevabiologics.com Open in urlscan Pro
176.28.33.163 Public Scan

Back to summary

Submitted URL:
https://eleva-biotech.ch/
Effective URL:
https://elevabiologics.com/
Submission: On November 02 via api (November 2nd 2023, 7:19:53 am UTC) from CH — Scanned from CH

Form analysis
1 forms found in the DOM

POST https://elevabiologics.com/

<form action="https://elevabiologics.com/" method="post" class="fusion-form fusion-form-4615">
  <div class="fusion-fullwidth fullwidth-box fusion-builder-row-10-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling"
    style="--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-flex-wrap:wrap;">
    <div class="fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap" style="width:104% !important;max-width:104% !important;margin-left: calc(-4% / 2 );margin-right: calc(-4% / 2 );">
      <div class="fusion-layout-column fusion_builder_column fusion-builder-column-41 fusion_builder_column_1_1 1_1 fusion-flex-column"
        style="--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;">
        <div class="fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column">
          <div class="fusion-form-field fusion-form-text-field fusion-form-label-above" style="" data-form-id="4615">
            <div class="fusion-form-label-wrapper"><label for="name">Name <abbr class="fusion-form-element-required" title="required">*</abbr></label></div><input type="text" name="name" id="name" value="" class="fusion-form-input" required="true"
              aria-required="true" data-holds-private-data="false" minlength="0">
          </div>
          <div class="fusion-form-field fusion-form-text-field fusion-form-label-above" style="" data-form-id="4615">
            <div class="fusion-form-label-wrapper"><label for="company">Company</label></div><input type="text" name="company" id="company" value="" class="fusion-form-input" data-holds-private-data="false" minlength="0">
          </div>
          <div class="fusion-form-field fusion-form-email-field fusion-form-label-above" style="" data-form-id="4615">
            <div class="fusion-form-label-wrapper"><label for="email">Email <abbr class="fusion-form-element-required" title="required">*</abbr></label></div><input type="email" name="email" id="email" value="" class="fusion-form-input"
              required="true" aria-required="true" data-holds-private-data="false">
          </div>
          <div class="fusion-form-field fusion-form-textarea-field fusion-form-label-above" style="" data-form-id="4615"><label for="your_message">Your message <abbr class="fusion-form-element-required" title="required">*</abbr></label><textarea
              cols="40" minlength="0" rows="4" tabindex="" id="your_message" name="your_message" class="fusion-form-input" required="true" aria-required="true" data-holds-private-data="false"></textarea></div>
          <div class="form-submission-notices data-notice_1" id="fusion-notices-1">
            <div class="fusion-form-response fusion-form-response-success">Thank you for your message. It has been sent.</div>
            <div class="fusion-form-response fusion-form-response-error">There was an error trying to send your message. Please try again later.</div>
          </div>
          <div class="fusion-form-field fusion-form-consent-field fusion-form-label-above" style="" data-form-id="4615">
            <div class="fusion-form-label-wrapper"><label for="consent">Consent <abbr class="fusion-form-element-required" title="required">*</abbr></label></div>
            <div class="fusion-form-checkbox option-inline"><input tabindex="" id="consent" type="checkbox" value="1" name="consent" class="fusion-form-input" required="true" aria-required="true"><label for="consent">I have taken note of the privacy
                policy.</label></div>
          </div>
          <div class="fusion-text fusion-text-10">
            <p><small>I consent to the processing of my personal data for the purpose of establishing contact in accordance with Article 6 paragraph 1 lit a of the Basic Data Protection Regulation (DSGVO).</small></p>
            <p><small>In accordance with Article 13 of the Basic Data Protection Regulation (DSGVO), we would like to provide you with comprehensive information about the processing of your personal data. You can read all relevant information in our
                data protection policy.</small></p>
          </div>
          <div class="fusion-form-field fusion-form-submit-field fusion-form-label-above" style="" data-form-id="4615">
            <div><button type="submit" class="fusion-button button-flat fusion-button-default-size button-default fusion-button-default button-5 fusion-button-span-yes  form-form-submit button-default" data-form-number="4615" tabindex=""><span
                  class="fusion-button-text">Submit</span></button></div>
          </div>
        </div>
      </div>
    </div>
  </div><input type="hidden" id="fusion-form-nonce-4615" name="fusion-form-nonce-4615" value="608f7c5c9c">
</form>

Text Content

Zum Inhalt springen
LATEST NEWS

Björn Cochlovius New CEO of Eleva
...
Eleva Enters Clinical Development of Difficult-To-Express High-Potential
Proteins
...
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development
of Factor H
...
Navigo Proteins and Eleva Announce Successful Development of an Affinity
Chromatography Resin Customized for the Efficient Purification of Human
Complement-Factor H
...
Eleva secures up to EUR 60 million to advance a drug candidate, appoints new
board member

UNLOCKING THE POWER
OF COMPLEX PROTEINS FOR
FUTURE THERAPIES

Toggle Navigation
 * Welcome
 * Assets
   * Complement
   * Enzyme replacement therapies
 * Platform
   * Publications
 * Company
   * Careers
 * Newsroom
 * Contact
   * Imprint
   * Privacy policy

Toggle Navigation
 * Welcome
 * Assets
   * Complement
   * Enzyme replacement therapies
 * Platform
   * Publications
 * Company
   * Careers
 * Newsroom
 * Contact
   * Imprint
   * Privacy policy


Welcome to elevaMarkus Reichert2023-10-24T14:42:55+02:00

MISSION


TOGETHER WITH PHARMACEUTICAL PARTNERS, WE DEVELOP DRUG CANDIDATES TO ADVANCE
INTO THE CLINIC

New solutions and new therapies need new avenues to reach them. The age of
cells producing biological compounds has achieved a lot for human medicine, but
its means are coming to an end. A step change in technology is required to
unleash the potential of molecules we didn’t dream we would discover – or be
able to create if we did.

ELEVA is opening this realm of unprecedented therapies with the help of
an inconspicuous but incredibly efficient tool: Bryophyta, more commonly known
as moss. This ancient organism holds the key to the therapies of the future.
Moss plants are not only able to produce the most complex and demanding
proteins; with their unique characteristics, they virtually invite easy, stable
engineering and reliable output.

WHAT WE OFFER


HOW ELEVA CAN CHANGE YOUR WORLD

We have harnessed the moss platform’s outstanding features to create candidates
and take them to clinical stages, ready for a bright future. Be our clinical
partner to develop unprecedented candidates into the therapies that will turn
around countless patient’s lives.

 * Are you looking for a partner with an asset that might be the key to a
   revolutionary treatment?

 * Are you struggling with a difficult protein?

 * Are you toying with a revolutionary toxin that targets just the right cells?

JOIN US AND OUR MOSS CELLS TO UNLEASH OPPORTUNITIES NEVER IMAGINED BEFORE, BASED
ON A PLATFORM THAT SURPASSES THE CAPACITIES OF ALL OTHER CELL LINES USED TO
DATE.

TALK TO US IF YOU ARE LOOKING AT PRODUCING

 * Antibodies

 * Biobetters

 * LSD enzymes

 * Fusion toxins

 * Virus-like particles/vaccines

 * Any complex, difficult protein

 * Efficient and effective glycosylation

PLATFORM


EVERYTHING YOU EXPECT FROM CELL LINE DEVELOPMENT
– YET WITHOUT THE PROBLEMS

Tailored Glycolysation
Flexible Genetic Engineering
Pathogen-Free Processing
Fusion Toxin Production

BUSINESS MODEL


AT ELEVA…

… we develop complex proteins into tomorrow’s drugs in partnership with
pharmaceutical companies

… we unlock the potential of difficult compounds that have so far failed to get
expressed

… we explore unusual opportunities in other promising fields

We have successfully developed enzymes and other proteins into clinical stages
and continue to scout for promising compounds. This results in a plethora of
opportunities. Whilst our technology platform remains the property of Eleva, new
individual assets will be developed in cooperation with pharmaceutical partners.
Each of such partnerships will be taken into a newly formed subsidiary. This
allows the partners to focus on the respective indication.


OUR PIPELINE


WE ARE INVITING PHARMACEUTICAL PARTNERS TO TAKE ALL CURRENT AND FUTURE
CANDIDATES TO CLINICAL SUCCESS.

INDICATION

RESEARCH

PRECLINICAL

PHASE I

PHASE II



THERAPIES FOR COMPLEMENT DISORDERS

C3 GLOMERULOPATHY (C3G)

Compleva FH/CPV-104 (natural complement regulator)


COMPLEMENT DISORDERS

Compleva MFHR1/CPV-102 (novel multi-level complement regulator)


COMPLEMENT DISORDERS

Compleva FHL/CPV-103 (natural complement regulator)



ENZYME REPLACEMENT THERAPIES

FABRY DISEASE

Repleva AGAL/RPV-001 (glyco-improved Fabry-ERT)


POMPE DISEASE

Repleva GAA/RPV-002 (glyco-improved Pompe-ERT)



RECENT NEWS

BJÖRN COCHLOVIUS NEW CEO OF ELEVA



Björn Cochlovius Ph.D. has become the new CEO of Eleva, a Freiburg-based biotech
company and the developer of “Bryotechnology”, a unique and pioneering process
for the moss-based production of complex therapeutic proteins. The renowned
oncologist, immunologist, and molecular biologist has nearly three decades of
experience in scientific, entrepreneurial, and advisory leadership roles in his
field.

Read More


ELEVA ENTERS CLINICAL DEVELOPMENT OF DIFFICULT-TO-EXPRESS HIGH-POTENTIAL
PROTEINS



Eleva, a manufacturer of superior biologics, is entering clinical phases with
its own drug candidates, such as immune-regulating factor H, as well as in
collaboration with pharmaceutical partners. Its moss-based platform is ideally
suited to produce difficult-to-express but therapeutically promising drug
candidates.

Read More


ELEVA REACHES INDUSTRIAL PRODUCTION SCALE AND PREPARES FOR CLINICAL DEVELOPMENT
OF FACTOR H



Eleva, a manufacturer of superior biologics, is scaling up its production
capacity to 2500 l in state-of-the-art single-use reactors. This will produce
sufficient quantities of factor H to cover all three clinical phases.

Read More




CONTACT

WE LOOK FORWARD TO HEARING FROM YOU!

eleva GmbH
Hans-Bunte-Str. 19
79108 Freiburg
Germany

Phone: +49 761 470 99 0
hello@elevabiologics.com


Name *
Company
Email *
Your message *
Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.
Consent *
I have taken note of the privacy policy.

I consent to the processing of my personal data for the purpose of establishing
contact in accordance with Article 6 paragraph 1 lit a of the Basic Data
Protection Regulation (DSGVO).

In accordance with Article 13 of the Basic Data Protection Regulation (DSGVO),
we would like to provide you with comprehensive information about the processing
of your personal data. You can read all relevant information in our data
protection policy.

Submit

eleva GmbH

Hans-Bunte-Str. 19
79108 Freiburg, Germany

Phone: +49 761 470 99 0
hello@elevabiologics.com

Contact | Imprint | Privacy Policy

© 2023 eleva GmbH

Page load link
Privacy settings

We use cookies on our website. Some of them are essential, while others help us
improve this website and your experience. Wenn Sie unter 16 Jahre alt sind und
Ihre Zustimmung zu freiwilligen Diensten geben möchten, müssen Sie Ihre
Erziehungsberechtigten um Erlaubnis bitten. Wir verwenden Cookies und andere
Technologien auf unserer Website. Einige von ihnen sind essenziell, während
andere uns helfen, diese Website und Ihre Erfahrung zu verbessern.
Personenbezogene Daten können verarbeitet werden (z. B. IP-Adressen), z. B. für
personalisierte Anzeigen und Inhalte oder Anzeigen- und Inhaltsmessung. Weitere
Informationen über die Verwendung Ihrer Daten finden Sie in unserer
Datenschutzerklärung. Sie können Ihre Auswahl jederzeit unter Einstellungen
widerrufen oder anpassen.

Privacy settings
 * Essenziell
   
   Essenzielle Cookies ermöglichen grundlegende Funktionen und sind für die
   einwandfreie Funktion der Website erforderlich.

 * Externe Medien
   
   Inhalte von Videoplattformen und Social-Media-Plattformen werden
   standardmäßig blockiert. Wenn Cookies von externen Medien akzeptiert werden,
   bedarf der Zugriff auf diese Inhalte keiner manuellen Einwilligung mehr.

Accept all

Save & close settings

Only accept essential cookies

Individual cookie settings

Cookie-Details Privacy policy Imprint
Privacy settings

Wenn Sie unter 16 Jahre alt sind und Ihre Zustimmung zu freiwilligen Diensten
geben möchten, müssen Sie Ihre Erziehungsberechtigten um Erlaubnis bitten. Wir
verwenden Cookies und andere Technologien auf unserer Website. Einige von ihnen
sind essenziell, während andere uns helfen, diese Website und Ihre Erfahrung zu
verbessern. Personenbezogene Daten können verarbeitet werden (z. B.
IP-Adressen), z. B. für personalisierte Anzeigen und Inhalte oder Anzeigen- und
Inhaltsmessung. Weitere Informationen über die Verwendung Ihrer Daten finden Sie
in unserer Datenschutzerklärung. Here you will find an overview of all cookies
used. You can give your consent to whole categories or have further information
displayed and thus select only certain cookies.

Accept all Save & close settings Only accept essential cookies

Back

Privacy settings
Essenziell (1)


Essenzielle Cookies ermöglichen grundlegende Funktionen und sind für die
einwandfreie Funktion der Website erforderlich.

Show Cookie Information Hide Cookie Information

Name Borlabs Cookie Anbieter Eigentümer dieser Website, Imprint Zweck Speichert
die Einstellungen der Besucher, die in der Cookie Box von Borlabs Cookie
ausgewählt wurden. Cookie Name borlabs-cookie Cookie Laufzeit 1 Jahr

Externe Medien (4)
Externe Medien

Inhalte von Videoplattformen und Social-Media-Plattformen werden standardmäßig
blockiert. Wenn Cookies von externen Medien akzeptiert werden, bedarf der
Zugriff auf diese Inhalte keiner manuellen Einwilligung mehr.

Show Cookie Information Hide Cookie Information

Akzeptieren Facebook Name Facebook Anbieter Meta Platforms Ireland Limited, 4
Grand Canal Square, Dublin 2, Ireland Zweck Wird verwendet, um Facebook-Inhalte
zu entsperren. Datenschutzerklärung https://www.facebook.com/privacy/explanation
Host(s) .facebook.com

Akzeptieren Google Maps Name Google Maps Anbieter Google Ireland Limited, Gordon
House, Barrow Street, Dublin 4, Ireland Zweck Wird zum Entsperren von Google
Maps-Inhalten verwendet. Datenschutzerklärung
https://policies.google.com/privacy Host(s) .google.com Cookie Name NID Cookie
Laufzeit 6 Monate

Akzeptieren Instagram Name Instagram Anbieter Meta Platforms Ireland Limited, 4
Grand Canal Square, Dublin 2, Ireland Zweck Wird verwendet, um Instagram-Inhalte
zu entsperren. Datenschutzerklärung https://www.instagram.com/legal/privacy/
Host(s) .instagram.com Cookie Name pigeon_state Cookie Laufzeit Sitzung

Akzeptieren Twitter Name Twitter Anbieter Twitter International Company, One
Cumberland Place, Fenian Street, Dublin 2, D02 AX07, Ireland Zweck Wird
verwendet, um Twitter-Inhalte zu entsperren. Datenschutzerklärung
https://twitter.com/privacy Host(s) .twimg.com, .twitter.com Cookie Name
__widgetsettings, local_storage_support_test Cookie Laufzeit Unbegrenzt

Privacy policy Imprint

Nach oben

elevabiologics.com Open in urlscan Pro 176.28.33.163 Public Scan

Form analysis 1 forms found in the DOM

POST https://elevabiologics.com/

Text Content

elevabiologics.com Open in urlscan Pro
176.28.33.163 Public Scan

Form analysis
1 forms found in the DOM